drug · small molecule
tavapadon
pre_registrationupdated 3mo agoby $ABBV AbbVie Inc.🔗 ChEMBL
community read0 votes
Small molecule drug with a maximum clinical stage of Phase 3 (across all indications), with 3 investigational indications.
indications
indications
Parkinson's Disease
targets
D(1A) dopamine receptorD(1B) dopamine receptor
all catalysts(0)
nothing on the calendar yet
Trials studying tavapadon
- —Expanded Access to Tavapadon
- phase3Open-label Trial in Parkinson's Disease (PD)
- phase3Flexible-Dose Trial in Early Parkinson's Disease (PD)
- phase3Fixed-Dose Trial in Early Parkinson's Disease (PD)
- phase1A Study to Assess the Relative Bioavailability of Oral Tavapadon in Healthy Adult Participants
- phase3Flexible-Dose, Adjunctive Therapy Trial in Adults With Parkinson's Disease With Motor Fluctuations (TEMPO-3)
- phase1To Evaluate Pharmacokinetics (PK) and Safety of Tavapadon in Participants With Severe Renal Impairment Compared to Participants With Normal Renal Function
- phase1Multiple-dose Trial to Determine the Clinical Bioequivalence Between Tavapadon Tablets in Participants With Parkinson's Disease
News(1)
- AbbVie shares pressured as Q2 I&I beat falls below investor expectationsAbbVie investors’ sky-high expectations led to a 4% share decline on Friday as the company reported more modest consensus beats than expected.biospace · 11d ago
Data sources
last refreshed 51m ago
Found something off?
comments(0)
5-min edit window · permanent after that